Sort
23,748 grants matching “melanoma”
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
$360,695Jiali Han · Brigham And Women'S Hospital · R01 · FY2010 · CA
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
$360,688Jiali Han · Brigham And Women'S Hospital · R01 · FY2008 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$360,682Iman Osman · New York University School Of Medicine · R01 · FY2022 · CA
ERK Signaling in Inflammatory Bone Loss
$360,675Francis Young-In Lee · Columbia University Health Sciences · R01 · FY2009 · AR
MODIFICATION OF HYPERTHERMIA RESPONSE
$360,540Thomas Jefferson University · P01 · FY2002 · CA
Enhanced diagnostic assessment in lupus using differential scanning calorimetry
$360,517Nichola C. Garbett · University Of Louisville · R01 · FY2017 · AI
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients
$360,411Eva Hernando · University Of New Mexico Health Scis Ctr · P01 · FY2018 · CA
Biological Imaging Core
$360,372Johannes Czernin · California Institute Of Technology · P01 · FY2014 · CA
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
$360,358Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2010 · CA
The Role of T Cell Avidity in Determining Tumor Immunity and Autoimmunity
$360,358Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Systemic RNA interference to reactivate p53 tumor suppression
$360,354Alexander H. Stegh · Northwestern University At Chicago · R01 · FY2017 · CA
The Role of CD5 in Tumor Immunity
$360,281Eynav Yafit Klechevsky · Washington University · R01 · FY2020 · CA
The Role of CD5 in Tumor Immunity
$360,281Eynav Yafit Klechevsky · Washington University · R01 · FY2021 · CA
The MC1R protein palmitoylation in melanoma development
$360,256Andrew W Taylor · Boston University Medical Campus · R01 · FY2019 · CA
Single Cell Genomics Core
$360,239Michael L Whitfield · Dartmouth College · P20 · FY2022 · GM
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$360,208Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2023 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$360,208Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2022 · CA
Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine
$360,206Tracy Onega · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Administrative Core
$360,188Meenhard Herlyn · Wistar Institute · U54 · FY2017 · CA
Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors
$360,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · EB
Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors
$360,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · EB
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
$360,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · DK
Low Electric Field-Based Gene Delivery of IL-30 Gene Therapy for Liver Injury
$360,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · DK
Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors
$360,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · EB
Mechanisms of Immune Evasion by Ocular Tumors
$359,964Kyle C McKenna · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · EY